Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD
Clinical trial NCT04632940 · TERMINATED
Trial details
- NCT number
- NCT04632940
- Sponsor
- Kyntra Bio
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2023-06-12
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.